ArticleCancers2025

Combining KPNA2 and FOXM1 Expression as Prognostic Markers and Therapeutic Targets in Hormone Receptor-Positive, HER2-Negative Breast Cancer.

Tsen-Long Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.